childhood
communityacquir
pneumonia
common
potenti
seriou
problem
worldwid
unless
patient
bacteraemia
pleural
empyema
aetiolog
diagnost
limit
antibiot
treatment
empir
publish
data
expect
respons
therapi
scarc
determin
clinic
respons
antibiot
treatment
develop
countri
otherwis
healthi
children
communityacquir
pneumonia
conduct
prospect
studi
hospitalis
children
pneumonia
role
microb
potenti
caus
agent
evalu
durat
fever
hospitalis
studi
object
measur
recoveri
potenti
aetiolog
found
patient
patient
sole
viral
sole
bacteri
mix
viralbacteri
infect
median
durat
fever
onset
antibiot
treatment
mainli
penicillin
g
h
median
durat
hospitalis
h
patient
mix
viralbacteri
infect
becam
afebril
slowli
either
sole
viral
sole
bacteri
infect
conclus
find
indic
develop
countri
children
pneumonia
make
rapid
unev
recoveri
need
short
hospit
stay
expens
timeconsum
microbiolog
investig
requir
bacteri
sepsi
exclud
childhood
communityacquir
pneumonia
cap
common
ill
annual
affect
ca
million
children
european
union
million
children
year
age
sever
direct
indirect
aetiolog
studi
suggest
streptococcu
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
haemophilu
influenza
common
bacteria
caus
cap
increas
lack
suscept
pneumonia
penicillin
macrolid
lack
suscept
pneumonia
c
pneumonia
betalactam
increas
betalactamas
product
h
influenza
suggest
one
singl
antibiot
may
effect
case
pneumonia
furthermor
cap
case
children
evid
viral
infect
surprisingli
comprehens
studi
antibiot
treatment
cap
children
report
develop
countri
prospect
placebocontrol
studi
report
explain
wide
variat
empir
treatment
recommend
limit
studi
data
avail
expect
respons
treatment
children
cap
report
clinic
respons
outcom
antibiot
treatment
children
hospitalis
uncompl
cap
care
defin
possibl
aetiolog
year
januari
decemb
patient
radiolog
confirm
childhood
cap
prospect
enrol
studi
depart
paediatr
turku
univers
hospit
main
caus
hospitalis
high
fever
dyspnoea
malaiselethargi
vomit
poor
appetit
diagnosi
base
simultan
find
infiltr
compat
pneumonia
chest
xray
film
well
sign
symptom
acut
infect
fever
role
microb
virus
bacteria
studi
detail
method
microbiolog
find
report
earlier
brief
antibodi
test
acut
convalesc
serum
sampl
use
bacteri
diagnosi
viral
diagnosi
base
viru
cultur
sensit
immunoassay
antigen
seven
virus
polymerasechainreact
assay
rhinovirus
nasopharyng
aspir
serolog
test
acut
convalesc
sera
blood
sampl
blood
cultur
taken
patient
one
patient
found
posit
pneumonia
patient
receiv
antibiot
treatment
hospitalis
patient
fever
ward
time
hospitalis
onset
antibiot
treatment
four
patient
complic
pneumonia
two
patient
empyema
one
patient
bronchiectasi
one
cystic
malform
lung
addit
patient
sever
underli
chronic
condit
six
genet
syndrom
six
neurocognit
disord
one
astrocytoma
patient
exclud
analysi
thu
patient
includ
studi
antibiot
treatment
chosen
attend
physician
median
age
patient
year
rang
year
twentyon
patient
month
age
month
age
year
age
year
age
older
patient
boy
patient
stabl
bronchial
asthma
atopi
prematur
congenit
heart
diseas
epilepsi
addit
bronchial
asthma
diabet
mellitu
recov
acut
lymphoblast
leukaemia
patient
healthi
durat
fever
durat
hospitalis
studi
object
measur
recoveri
data
record
patient
chart
hour
bodi
temperatur
measur
rectal
patient
year
age
axilla
children
year
age
temperatur
measur
ward
everi
h
temperatur
found
normal
durat
fever
mark
h
h
period
patient
febril
patient
treat
paracetamol
naproxen
followup
examin
carri
week
discharg
addit
care
histori
time
discharg
clinic
examin
blood
sampl
viral
bacteri
serolog
chest
radiograph
taken
pearson
standard
chisquar
test
use
compar
proport
group
fisher
exact
test
expect
count
less
mannwhitney
test
determin
statist
differ
continu
variabl
differ
durat
fever
separ
infect
group
fig
analys
use
surviv
analysi
approach
logit
model
discret
respons
variabl
analys
done
use
probit
procedur
sa
system
window
version
pyogen
bordetella
pertussi
patient
common
viralbacteri
infect
rhinoviru
pneumonia
rsv
pneumonia
infect
admiss
median
wbc
l
median
level
serum
crp
mgl
patient
alveolar
infiltr
chest
xray
film
sole
bacteri
viral
pneumonia
differ
significantli
number
alveolar
pneumonia
median
crp
median
wbc
tabl
hospitalis
median
durat
fever
children
day
rang
day
ward
median
durat
fever
onset
antibiot
treatment
h
rang
h
tabl
interestingli
durat
fever
patient
sole
bacteri
sole
viral
infect
similar
patient
mix
viral
bacteri
infect
longer
durat
fever
onset
antibiot
treatment
fig
find
statist
signific
obtain
patient
sole
concomit
infect
exclud
rsv
pneumonia
mix
rsv
pneumonia
pneumonia
compar
fig
patient
fever
last
h
onset
antibiot
treatment
fever
last
h
consid
treatment
failur
record
children
tabl
fig
half
patient
treatment
failur
evid
mix
viralbacteri
infect
three
sole
viral
infect
two
sole
bacteri
infect
one
patient
possibl
aetiolog
found
pathogen
usual
found
patient
treatment
failur
rsv
h
influenza
seven
patient
fever
last
h
one
sole
bacteri
infect
h
influenza
two
patient
fever
h
viral
one
influenza
viru
one
rsv
coronaviru
infect
median
durat
hospit
stay
h
rang
h
patient
treat
intraven
penicillin
g
cefuroxim
rest
antibiot
tabl
penicillin
treatment
group
show
trend
treatment
failur
children
either
b
pertussi
c
pneumonia
catarrhali
pneumonia
pneumonia
penicillinnonsuscept
bacteria
compar
children
sole
pneumonia
pneumonia
versu
patient
respect
initi
antibiot
therapi
chang
six
patient
three
sole
viral
two
mix
viralbacteri
infect
one
patient
aetiolog
establish
discharg
children
receiv
oral
antibiot
total
durat
antibiot
treatment
day
seven
patient
fever
home
immedi
discharg
hospit
four
mix
viralbacteri
infect
two
sole
bacteri
infect
one
sole
viral
infect
followup
examin
carri
children
day
median
day
admiss
recurr
pneumonia
record
patient
report
parent
free
caprel
symptom
howev
patient
receiv
second
antibiot
treatment
followup
mainli
acut
otiti
media
found
studi
children
rapidli
recov
cap
onset
antibiot
therapi
one
develop
complic
antibiot
treatment
patient
becam
afebril
within
h
median
durat
hospit
stay
h
detail
find
consist
earlier
studi
develop
countri
independ
aetiolog
type
antibiot
use
children
uncompl
cap
found
afebril
clinic
improv
within
h
start
antibiot
clinic
respons
often
reportedli
good
lead
cure
cap
patient
without
detail
daili
data
recoveri
even
children
bacteraem
pneumococc
pneumonia
becom
afebril
within
averag
h
onset
antimicrobi
therapi
rapid
clinic
recoveri
associ
rapid
normalis
wbc
crp
sharp
contrast
data
pneumonia
lessdevelop
countri
sever
pneumonia
common
patient
die
spite
parenter
antibiot
treatment
treatment
failur
rare
patient
nonsever
pneumonia
patient
one
studi
still
caprel
symptom
day
children
cap
fever
h
onset
antibiot
treatment
patient
evid
viral
infect
usual
concomit
bacteri
infect
mani
find
support
view
mix
viralbacteri
infect
may
common
earlier
recognis
may
induc
sever
inflamm
clinic
ill
sole
bacteri
sole
viral
infect
concomit
influenza
viru
staphylococcu
aureu
infect
may
caus
sever
fatal
pneumonia
children
adult
one
studi
children
acut
otiti
media
show
bacteria
viru
middl
ear
fluid
fail
respond
therapi
often
group
bacteria
alon
common
cold
studi
patient
viru
pneumonia
h
influenza
catarrhali
nasopharynx
symptom
viru
alon
furthermor
anoth
studi
patient
common
cold
seem
benefit
antibiot
therapi
surpris
find
children
sole
viral
pneumonia
show
respons
antibiot
treatment
similar
sole
bacteri
pneumonia
find
obtain
sole
rsv
sole
pneumococc
pneumonia
studi
argu
patient
cap
may
bacteri
pneumonia
test
use
detect
bacteri
infect
insensit
support
find
pneumolysin
pcr
analysi
blood
sampl
may
detect
case
overlook
serolog
furthermor
serolog
test
detect
blood
cultur
posit
case
hand
patient
sole
bacteri
pneumonia
differ
significantli
sole
viral
pneumonia
laboratori
chest
radiographi
find
show
serolog
test
detect
bacteri
type
infect
anoth
explan
could
high
spontan
cure
rate
cap
children
studi
acut
otiti
media
acut
sinus
also
shown
penicillin
g
still
consid
drug
choic
hospitalis
children
cap
mani
european
countri
low
penicillin
resist
pneumococci
patient
treat
penicillin
g
show
rapid
unev
recoveri
penicillin
g
longer
recommend
unit
state
firstchoic
drug
limit
suppli
increas
resist
pneumococci
penicillin
wherea
finland
pneumococc
strain
remain
sensit
penicillin
patient
receiv
day
parenter
treatment
success
switch
oral
treatment
earlier
studi
shown
major
children
cap
treat
outpati
one
inject
cephalosporin
limit
studi
must
admit
studi
otherwis
healthi
children
highli
develop
countri
includ
children
alreadi
complic
pneumonia
ie
empyema
two
children
admiss
onset
antibiot
treatment
rel
frequenc
empyema
increas
often
requir
prolong
hospitalis
indirect
evid
aetiolog
cap
obtain
causal
consid
caution
result
show
cap
children
develop
countri
seriou
ill
clinic
practic
nearli
otherwis
healthi
children
pneumonia
becom
afebril
within
day
make
unev
recoveri
etiolog
investig
need
plan
therapi
children
short
parenter
treatment
period
need
patient
treat
oral
antibiot
outpati
